# Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving Antiplatelet Therapy With Clopidogrel (Plavix)

> **NCT00257751** · NA · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Aprotinine

## Key facts

- **NCT ID:** NCT00257751
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2011-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257751, "Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving Antiplatelet Therapy With Clopidogrel (Plavix)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00257751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*